Suppr超能文献

诊断前血清激素与前列腺癌风险

Prediagnostic serum hormones and the risk of prostate cancer.

作者信息

Nomura A, Heilbrun L K, Stemmermann G N, Judd H L

机构信息

Japan-Hawaii Cancer Study, Kuakini Medical Center, Honolulu 96817.

出版信息

Cancer Res. 1988 Jun 15;48(12):3515-7.

PMID:3370644
Abstract

Serum samples were obtained from 6860 men during their study examination from 1971 to 1975. After a surveillance period of about 14 years, 98 incident cases of prostate cancer were identified. Their stored sera and that of 98 matched controls from the study population were tested for the following: testosterone, dihydrotestosterone, estrone, estradiol, and sex hormone globulin. There was a suggestion that serum dihydrotestosterone levels were lower and the testosterone/dihydrotestosterone ratios were higher in the prostate cancer cases compared with their controls. However, none of these associations or that of the other hormones was strongly significant. Further work is needed to clarify the relationship between sex hormones and prostate cancer risk.

摘要

1971年至1975年研究检查期间,从6860名男性身上采集了血清样本。经过约14年的监测期,确定了98例前列腺癌新发病例。对他们储存的血清以及来自研究人群的98名匹配对照的血清进行了以下检测:睾酮、双氢睾酮、雌酮、雌二醇和性激素结合球蛋白。有迹象表明,与对照组相比,前列腺癌病例的血清双氢睾酮水平较低,睾酮/双氢睾酮比值较高。然而,这些关联以及其他激素的关联均无显著意义。需要进一步开展工作以阐明性激素与前列腺癌风险之间的关系。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验